How Cysts Grow

The Two Driving Forces of Cyst Growth

Once a quiste forms, its continued growth is driven by two core mechanisms:

1. Proliferation of quiste-lining epithelial células: The cAMP-ERK and mTOR pathways drive continuous division of quiste-wall células, increasing the surface area of the quiste wall.
2. Fluid secreción into the quiste lumen: The CFTR chloride channel mediates chloride secreción, with sodio following passively and water entering by osmosis, increasing quiste volume.

These two processes reinforce each other — more células produce more secretory surface area, and a larger lumen provides more room for growth. This is why quistes grow exponentially, not linearly.

The cAMP-PKA Pathway: The Core Engine of Cyst Growth

In polyquisteic riñón células, cAMP drives crecimiento de quistes through two downstream pathways:

• B-Raf → MEK → ERK pathway: Promotes célula proliferación. In normal células, cAMP inhibits B-Raf, but in polyquisteic riñón células the reduced intracélulaular calcio reverses this response, and cAMP instead activates B-Raf.
• PKA → CFTR pathway: PKA phosphorylates and opens the CFTR chloride channel, driving fluid secreción.

The primary source of cAMP is activation of the vasopresina receptor V2 (V2R). Vasopressin binds to V2R on the surface of conducto colector principal células, activating adenylyl cyclase 6 (AC6) via the Gs proteína, which genrates large amounts of cAMP. This is why blocking V2R (tolvaptán) can efectivoly slow crecimiento de quistes.

However, completely blocking the cAMP-PKA pathway is not feasible — cAMP has many important functions in normal células. Therefore, investigación is exploring the possibility of targeting downstream cAMP pathways (such as ERK and CFTR) to inhibit crecimiento de quistes while preserving normal cAMP function.

The CFTR Chloride Channel: The Molecular Basis of Fluid Secretion

The key to quiste fluid secreción is the CFTR (quisteic fibrosis transmembrane conductance regulator) chloride channel. In normal conducto colector células, CFTR participates in chloride secreción to maintain electrolyte balance of tubular fluid. In enfermedad renal poliquística:

1. cAMP-PKA phosphorylates CFTR, causing it to open.
2. Chloride ions are secreted from quiste-wall células into the quiste lumen.
3. Sodium ions follow chloride via the paracélulaular pathway.
4. Water follows the salt into the quiste lumen by osmosis.

This process is similar to normal renal tubular fluid secreción, but in quistes it has lost its regulatory control and continues unabated. CFTR inhibitors can reduce quiste fluid secreción in vitro, but clínico application is not yet mature.

Metabolic Reprogramming: The Energy Source of Cyst Cells

The metabolic pattern of quiste células undergoes significant changes, similar to the Warburg effect in tumor células:

• Enhanced aerobic glycolysis: ATP is preferentially produced through glycolysis, even under aerobic conditions. This leads to increased glucose consumption and lactate production.
• Suppressed mitochondrial oxidative phosphorylation: Mitochondrial function declines, and fatty acid oxidation decreases.
• Glutamine dependence: Cyst células rely on glutamine as an energy source and biosynthetic precursor.

This metabolic alteration is driven by mTORC1, HIF-1α, c-MYC, and others. Gene expression analysis of human PKD1 riñón tejido has confirmed these features. The significance of metabolic reprogramming:

• It provides a theoretical basis for dietary interventions — carbohydrate restriction and ketogenic diets slow crecimiento de quistes in modelo animals, but human evidencia is insufficient.
• It provides targets for novel drugs — GLP-1 receptor agonists (semaglutide) slow crecimiento de quistes in modelo animals by regulating glycolysis and mitochondrial function; ensayo en humanoss are underway.

Impaired Autophagy: Reduced Cellular Cleanup Capacity

Autophagy is the mechanism by which células clear damaged órganoelles and proteínas. In enfermedad renal poliquística, abnormal mTOR activation suppresses autophagic flux, leading to intracélulaular waste accumulation and exacerbating célulaular estrés and injury.

In a zebrafish pkd1 mutant model, autophagy activators (rapamicina, carbamazepine, minoxidil) significantly inhibited formación de quistes. This suggests that autophagy is a potential therapeutic target for ADPKD, but it remains in the preclínico estadio.

From Cysts to Fibrosis: The Critical Turning Point

Cyst growth itself is not the direct cause of función renal loss — even if the riñóns are filled with quistes, if the quistes do not compress normal tejido, función renal can be maintained. The core mechanism of función renal loss is ischemia and fibrosis caused by quiste compression.

Compression and Ischemia

As quistes enlarge, they compress surrounding structures:

• Renal túbulos: Compressed túbulos atrophy and become occluded, losing function.
• Peritubular capillaries: Reduced blood flow leads to local ischemia, and hypoxia further promotes fibrosis.
• Lymphatic vessels: Lymphatic drainage is obstructed, worsening interstitial edema and inflamación.

Interstitial Fibrosis

Ischemia and inflamación activate interstitial fibroblasts, which transform into myofibroblasts that secrete large amounts of collagen and extracélulaular matrix, forming interstitial fibrosis. Fibrotic tejido replaces normal renal interstitium, further reducing blood flow and oxygen supply, creating a vicious cycle.

Tubular atrophy and interstitial fibrosis are irreversible structural damage. This is why eGFR decline typically appears only after many years of crecimiento de quistes — when structural damage accumulates to a certain threshold, función renal begins to decline rapidly.

Structural Progression Precedes Functional Decline

The CRISP prospective estudio confirmed that volumen total renal (TKV) growth in ADPKD precedes eGFR decline by many years. The annual TKV growth rate is a key predictor of future eGFR decline. This is why:

• Regular monitoreo of TKV is important — it can identify rapid progressors before función renal declines.
• Tolvaptan is more efectivo in early-estadio pacientes — intervening when structural damage is still reversible.
• The PROPKD score combines TKV growth rate for estratificación de riesgo — identifying pacientes who need targeted therapy.

Factors Affecting Cyst Growth Rate

Cyst growth rates vary greatly between pacientes. Factors affecting growth rate include:

• Genotype: PKD1 mutación truncantes > PKD1 missense mutacións > PKD2 mutacións.
• Baseline TKV: Larger baseline riñón volume correlates with faster growth.
• Blood pressure: Hypertension is associated with faster crecimiento de quistes.
• Sodium intake: High urinario sodio excreción is associated with faster TKV growth and eGFR decline.
• Vasopressin levels: Elevated copeptin predicts faster progresión.
• HDL colesterol: Low HDL is associated with faster progresión.
• Age and sex: Males typically progress slightly faster than females.

Why Early Intervention Matters

Because crecimiento de quistes is exponential and structural damage (fibrosis) is irreversible, early intervention is critical:

• When quistes are smaller and fibrosis is less extensive, blocking the V2R-cAMP pathway can maximally slow crecimiento de quistes.
• Once extensive fibrosis has formed, even if crecimiento de quistes is halted, the lost función renal cannot be recovered.
• This is why the KDIGO 2025 guía recommends early initiation of tolvaptán for pacientes at high riesgo of rapid progresión.

However, early intervention also requires trade-offs — the efecto secundarios of tolvaptán (polyuria and thirst, hepatotoxicity) and its impact on calidad de vida. Whether to initiate tratamiento requires a shared decision between you and your doctor, based on your estratificación de riesgo and personal preferences.

← Back to Knowledge Base